Concepedia

Publication | Open Access

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease

32

Citations

28

References

2022

Year

Abstract

In this study, 57% of N-ERD patients tolerated higher doses of aspirin under dupilumab therapy.

References

YearCitations

Page 1